Back to Search Start Over

Personalise treatment for rosacea by selecting from a range of options for individual features.

Personalise treatment for rosacea by selecting from a range of options for individual features.

Authors :
Nie, Tina
Source :
Drugs & Therapy Perspectives. Jun2024, Vol. 40 Issue 6, p221-225. 5p.
Publication Year :
2024

Abstract

Rosacea is a chronic, inflammatory condition of facial skin. Treatment of rosacea should be based on its presenting features i.e. inflammatory lesions, erythema, phymas and/or telangiectasia. First-line treatment options for inflammatory lesions include metronidazole, azelaic acid, ivermectin and modified-release doxycycline, but topical formulations of minocycline foam and encapsulated benzoyl peroxide are also now available. Persistent erythema can be treated with topical α-adrenergic receptor agonists or light-based therapies. Approved pharmacological options for phymas and telangiectasia are limited; nonpharmacological procedures should be considered in some cases. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
11720360
Volume :
40
Issue :
6
Database :
Academic Search Index
Journal :
Drugs & Therapy Perspectives
Publication Type :
Academic Journal
Accession number :
178778126
Full Text :
https://doi.org/10.1007/s40267-024-01081-w